Risk factor analysis of 115 children and adolescents with primary mediastinal B-cell lymphoma treated with DA-EPOCH-R
Year: 2026
Type: article
Abstract: International audience
Source: Blood Advances
Authors: Friederike Meyer-Wentrup, Sarah Flora Jonas, Fabian Knoerr, Anne Auperin, Sarah Alexander, Mara Andres, Andishe Attarbaschi, G. A. Amos Burke, Birgit Burkhardt, Francesco Ceppi, Thomas Gross, Edita Kabickova, Wolfram Klapper, Rodney R. Miles, Mary Taj, Martin Zimmermann, Veronique Minard-Colin, Wilhelm Woessmann
Institutions: Princess Máxima Center, Inserm, Université Paris-Saclay, Institut Gustave Roussy, University Medical Center Hamburg-Eppendorf, University of British Columbia, BC Children's Hospital, Hospital Universitari i Politècnic La Fe, St Anna Children's Hospital, St. Anna Children's Cancer Research Institute, Medical University of Vienna, Cancer Research UK Clinical Trials Unit, University of Birmingham, University Hospital Münster, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Phoenix Children's Hospital, Charles University, University Hospital in Motol, Christian-Albrechts-Universität zu Kiel, University Hospital Schleswig-Holstein, University of Utah, Huntsman Cancer Institute, Royal Marsden NHS Foundation Trust, Royal Marsden Hospital, Medizinische Hochschule Hannover, Immunologie anti-tumorale et immunothérapie des cancers
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,800
OpenAlex ID: W7154268135
FWCI:
Cites:
Cited by:
Related to: